CIM Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$714K Buy
9,121
+629
+7% +$42.9K 0.17% 94
2026
Q1
$549K Sell
8,492
-137
-2% -$9.66K 0.15% 120
2025
Q4
$581K Hold
8,629
– – 0.15% 111
2025
Q3
$633K Sell
8,629
-9,295
-52% -$617K 0.17% 99
2025
Q2
$894K Buy
17,924
+8,995
+101% +$512K 0.17% 113
2025
Q1
$570K Sell
8,929
-213
-2% -$12.4K 0.13% 107
2024
Q4
$437K Hold
9,142
– – 0.13% 133
2024
Q3
$523K Hold
9,142
– – 0.15% 116
2024
Q2
$479K Sell
9,142
-2,180
-19% -$95.6K 0.15% 130
2024
Q1
$461K Buy
11,322
+3,331
+42% +$125K 0.14% 150
2023
Q4
$295K Hold
7,991
– – 0.1% 205
2023
Q3
$305K Hold
7,991
– – 0.11% 179
2023
Q2
$288K Buy
7,991
+2,736
+52% +$93.3K 0.1% 194
2023
Q1
$201K Buy
+5,255
New +$246K 0.07% 242
2022
Q4
– Sell
-7,769
Closed -$307K – 253
2022
Q3
$307K Buy
7,769
+1,570
+25% +$69.4K 0.14% 154
2022
Q2
$273K Buy
6,199
+1,091
+21% +$47.2K 0.11% 175
2022
Q1
$204K Sell
5,108
-604
-11% -$21.5K 0.07% 232
2021
Q4
$230K Hold
5,712
– – 0.07% 260
2021
Q3
$232K Hold
5,712
– – 0.07% 254
2021
Q2
$259K Hold
5,712
– – 0.08% 238
2021
Q1
$238K Buy
+5,712
New +$261K 0.07% 256

Other funds holding HALO

CIM Investment Management's HALO Position: Q2 2026 in Review

CIM Investment Management increased its Halozyme (HALO) stake by 7.4% in Q2 2026, buying an estimated $42.9K and bringing the position to 9,121 shares worth $714K. The position accounts for 0.17% of the portfolio, ranked #94.

CIM Investment Management first reported a position in HALO in Q1 2021 and has held it in 21 quarters since. The position peaked at $894K in Q2 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • CIM Investment Management held 9,121 shares of Halozyme worth $714K as of Q2 2026.
  • CIM Investment Management bought 629 Halozyme shares in Q2 2026, an estimated $42.9K.
  • Halozyme made up 0.17% of CIM Investment Management's portfolio in Q2 2026, its #94 holding.
  • CIM Investment Management first reported a position in Halozyme in Q1 2021 and has held it in 21 quarters since.
  • CIM Investment Management's Halozyme position peaked at $894K in Q2 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.